LifeStance Health Enters/Terminates Material Agreements
Ticker: LFST · Form: 8-K · Filed: Dec 19, 2024 · CIK: 1845257
| Field | Detail |
|---|---|
| Company | Lifestance Health Group, Inc. (LFST) |
| Form Type | 8-K |
| Filed Date | Dec 19, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01, $290.0 million, $100.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation, agreement-termination
Related Tickers: LIFTD
TL;DR
LIFTD entered new deals and ditched old ones on Dec 19. Financial impact TBD.
AI Summary
LifeStance Health Group, Inc. entered into a material definitive agreement on December 19, 2024, related to a direct financial obligation. The company also terminated a material definitive agreement on the same date. Specific details of the agreements and their financial implications were not fully disclosed in this initial filing.
Why It Matters
This filing indicates significant changes in LifeStance Health's contractual and financial obligations, which could impact its operational structure and financial health.
Risk Assessment
Risk Level: medium — The filing mentions both the entry into and termination of material definitive agreements, suggesting potential shifts in financial obligations or strategic partnerships that warrant closer examination.
Key Players & Entities
- LifeStance Health Group, Inc. (company) — Registrant
- December 19, 2024 (date) — Date of earliest event reported
FAQ
What was the nature of the material definitive agreement entered into by LifeStance Health Group, Inc. on December 19, 2024?
The filing states that LifeStance Health Group, Inc. entered into a material definitive agreement on December 19, 2024, which resulted in a direct financial obligation or an obligation under an off-balance sheet arrangement.
What was the reason for the termination of a material definitive agreement by LifeStance Health Group, Inc. on December 19, 2024?
The filing indicates that LifeStance Health Group, Inc. terminated a material definitive agreement on December 19, 2024, but does not provide the specific reason for this termination.
What is the Commission File Number for LifeStance Health Group, Inc.?
The Commission File Number for LifeStance Health Group, Inc. is 001-40478.
Where is LifeStance Health Group, Inc.'s principal executive office located?
LifeStance Health Group, Inc.'s principal executive offices are located at 4800 N. Scottsdale Road, Suite 2500, Scottsdale, Arizona, 85251.
What is the SIC code for LifeStance Health Group, Inc.?
The Standard Industrial Classification (SIC) code for LifeStance Health Group, Inc. is 8000, which falls under SERVICES-HEALTH SERVICES.
Filing Stats: 1,158 words · 5 min read · ~4 pages · Grade level 13.1 · Accepted 2024-12-19 16:30:52
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share LFST The Nasdaq Stock Mar
- $290.0 million — a senior secured term loan facility of $290.0 million (the "Term Loan Facility"), which was f
- $100.0 million — ecured revolving loan facility of up to $100.0 million (the "Revolving Facility"). The commitm
Filing Documents
- d886973d8k.htm (8-K) — 29KB
- 0001193125-24-282043.txt ( ) — 149KB
- lfst-20241219.xsd (EX-101.SCH) — 3KB
- lfst-20241219_lab.xml (EX-101.LAB) — 18KB
- lfst-20241219_pre.xml (EX-101.PRE) — 11KB
- d886973d8k_htm.xml (XML) — 4KB
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K contains certain forward-looking statements within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include availability of commitments under the 2024 Credit Agreement. Words such as "may," "will," "should," "could," "intend," "potential," "continue," "anticipate," "believe," "estimate," "expect," "plan," "target," "predict," "project," "seek" and similar expressions as they relate to us are intended to identify forward-looking statements. They involve a number of risks and uncertainties that may cause actual events and results to differ materially from such forward-looking statements. These risks and uncertainties include, but are not limited to, those related to market conditions; funding conditions related to the 2024 Credit Agreement; that the Company's existing indebtedness could adversely affect its business and growth prospects; and other risks and uncertainties set forth under "Risk Factors" included in the reports the Company has filed or will file with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2023. LifeStance does not undertake to update any forward-looking statements made in this Form 8-K to reflect any change in management's expectations or any change in the assumptions or circumstances on which such statements are based, except as otherwise required by law. Item1.02 Termination of a Material Definitive Agreement. The information included in Item 1.01 of this Current Report on Form 8-K regarding the termination of the Existing Credit Agreement is incorporated by reference into this Item 1.02. Item2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth above under Item 1.01 of this Current Report on Form 8-K relating to the 2024 Credit Agreement is incorporated by refe
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. LifeStance Health Group, Inc. Date: December 19, 2024 By: /s/ David Bourdon David Bourdon Chief Financial Officer and Treasurer (principal financial and accounting officer)